Form 8-K - Current report:
SEC Accession No. 0001193125-25-129494
Filing Date
2025-05-28
Accepted
2025-05-28 16:13:36
Documents
42
Period of Report
2025-05-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d904503d8k.htm   iXBRL 8-K 30354
2 EX-99.1 d904503dex991.htm EX-99.1 35675
3 EX-99.2 d904503dex992.htm EX-99.2 43532
7 GRAPHIC g904503ex99_2s10g1.jpg GRAPHIC 149487
8 GRAPHIC g904503ex99_2s11g1.jpg GRAPHIC 114207
9 GRAPHIC g904503ex99_2s12g1.jpg GRAPHIC 54945
10 GRAPHIC g904503ex99_2s13g1.jpg GRAPHIC 128422
11 GRAPHIC g904503ex99_2s14g1.jpg GRAPHIC 108038
12 GRAPHIC g904503ex99_2s15g1.jpg GRAPHIC 41088
13 GRAPHIC g904503ex99_2s16g1.jpg GRAPHIC 120048
14 GRAPHIC g904503ex99_2s17g1.jpg GRAPHIC 137088
15 GRAPHIC g904503ex99_2s18g1.jpg GRAPHIC 156269
16 GRAPHIC g904503ex99_2s19g1.jpg GRAPHIC 110681
17 GRAPHIC g904503ex99_2s1g1.jpg GRAPHIC 80509
18 GRAPHIC g904503ex99_2s20g1.jpg GRAPHIC 102537
19 GRAPHIC g904503ex99_2s21g1.jpg GRAPHIC 103382
20 GRAPHIC g904503ex99_2s22g1.jpg GRAPHIC 90810
21 GRAPHIC g904503ex99_2s23g1.jpg GRAPHIC 87407
22 GRAPHIC g904503ex99_2s24g1.jpg GRAPHIC 103673
23 GRAPHIC g904503ex99_2s25g1.jpg GRAPHIC 121479
24 GRAPHIC g904503ex99_2s26g1.jpg GRAPHIC 70118
25 GRAPHIC g904503ex99_2s27g1.jpg GRAPHIC 26464
26 GRAPHIC g904503ex99_2s28g1.jpg GRAPHIC 211899
27 GRAPHIC g904503ex99_2s2g1.jpg GRAPHIC 211568
28 GRAPHIC g904503ex99_2s3g1.jpg GRAPHIC 53785
29 GRAPHIC g904503ex99_2s4g1.jpg GRAPHIC 62491
30 GRAPHIC g904503ex99_2s5g1.jpg GRAPHIC 55975
31 GRAPHIC g904503ex99_2s6g1.jpg GRAPHIC 101762
32 GRAPHIC g904503ex99_2s7g1.jpg GRAPHIC 153176
33 GRAPHIC g904503ex99_2s8g1.jpg GRAPHIC 119221
34 GRAPHIC g904503ex99_2s9g1.jpg GRAPHIC 108420
  Complete submission text file 0001193125-25-129494.txt   4368482

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tsha-20250528.xsd EX-101.SCH 2845
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsha-20250528_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsha-20250528_pre.xml EX-101.PRE 11704
44 EXTRACTED XBRL INSTANCE DOCUMENT d904503d8k_htm.xml XML 3767
Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Filer) CIK: 0001806310 (see all company filings)

EIN.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39536 | Film No.: 25995553
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)